Notably, Louandre et al. found that inactivation of retinoblastoma (Rb) may contribute to the antitumor effect of sorafenib on HCC by sensitizing HCC cells to ferroptosis (Louandre et al., 2015). Here, RB1 is linked to hepatocellular carcinoma.